Other Transaction Agreement W911SR269A009
Award Date 6/1/26
Potential Completion Date 5/31/29
Potential Value $9.5M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Set-Aside Type
Not listed Federal Contract Vehicle
- Not listed
Extent Competed
Competed
Major Defense Program
Not listed Pricing Type
Other
Place of Performance
Medford, MA 02155, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $13,424,714.14 Other Transaction Agreement (OTA) to Sunflower Therapeutics PBC, a woman-owned small business, for the development of a Biologics on Demand Platform Prototype. The contract, which does not have a set-aside designation, was awarded on August 6, 2019, with a completion date of July 15, 2022. This OTA is part of the Department of the Army's efforts to advance chemical and...
- The Office of the Secretary of Defense awarded an Other Transaction Agreement to Advanced Technology International for the Advanced Biological Defeat Trauma System with a ceiling value of $5,265,329.58, effective December 16, 2024. This OTA sits outside the FAR and operates under statutory authority that permits flexible acquisition of prototype and R&D capabilities. Memsel Inc. serves as the primary consortia member. The agreement involves updating the Statement of Work for the ongoing...
- The Department of the Army awarded an Other Transaction Agreement to Teledyne Flir Defense, Inc. on March 16, 2026, with a ceiling value of $13.8 million to develop next-generation sensors and integrate them into existing unmanned platforms for enhanced chemical and biological hazard detection. The prototype OTA extends through September 22, 2028. Work is performed in Stillwater, Oklahoma. The agreement sits outside the FAR and operates under statutory authority for prototype other transactions....
- The Defense Health Agency awarded an Other Transaction Agreement to Camris International, LLC for an innovative bio-production business process supporting the Walter Reed Army Institute of Research Pilot Bio-Production Facility, with a ceiling value of $90,176,697.85 and an award date of February 14, 2020. This prototype OTA sits outside the FAR and funds development of novel manufacturing processes and business models for the facility located in Bethesda, Maryland. The agreement extends through...
- The Office of the Secretary of Defense awarded an Other Transaction Agreement to TEC Solutions LLC for $44,929,368.21 on March 23, 2026, under the authority of 10 U.S.C. § 4022 to develop a Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) Enterprise Productivity and Coordination Platform. This prototype OTA sits outside the FAR and supports DoD's small business innovation research ecosystem. Work is performed in Arlington, Virginia, with an ultimate completion...
- The Defense Health Agency awarded an Other Transaction Order to Medical Technology Enterprise Consortium for the Armed Forces Institute for Regenerative Medicine research project, with a ceiling value of $57.8 million and an award date of September 15, 2023. The order funds research into regenerative medicine solutions for military personnel healthcare applications. Place of performance is Summerville, SC. The ultimate completion date is December 23, 2028. MTEC, a nonprofit medical technology...
- The Defense Threat Reduction Agency awarded an Other Transaction order to Advanced Technology International for development of an interstitial fluid microsampler device and microanalysis methods to enable more frequent measurements of immunomarkers in mice for vaccine development, with a ceiling value of $4.27 million and an award date of April 9, 2026. Place of performance is Huntsville, AL. The ultimate completion date is April 15, 2029. Advanced Technology International is a public service...
- The Office of the Assistant Secretary for Preparedness and Response, within the Department of Health and Human Services, awarded an Other Transaction Agreement to On Demand Pharmaceuticals Inc. with a ceiling value of $16.25 million on June 1, 2024, for CGMP medicine manufacturing as a prototype for a distributed network, specifically for production of cisatracurium drug substance (API) and drug product. The OTA is structured outside the FAR and reflects HHS ASPR's authority to use alternative...
- The Defense Advanced Research Projects Agency awarded an Other Transaction Agreement to Marwell Bio Inc. for $1,350,000 on April 2, 2026, supporting the Biological Technologies Office's Network of Optimal Dynamic Energy Signatures (NODES) program focused on generalized embeddings with sequence-to-functions annotations for antibody design. This OTA sits outside the Federal Acquisition Regulation and operates under DARPA's authority for prototype or R&D efforts. Work is performed in South...
- U.S. Army Research Development and Engineering Command awarded an Other Transaction Agreement to Advanced Technology International (prime awardee) for Multi-Domain Autonomous Precision Targeting Software for Collaborative Platforms, with a ceiling value of $10,154,846.05 and an award date of September 17, 2024. This modification adds additional funding to the existing agreement. Apollotech MSI Corp serves as the primary consortia member. The ultimate completion date is September 17, 2029. Work...
RDECOM awarded an Other Transaction Agreement to Sunflower Therapeutics PBC for $9,515,785.84 on June 1, 2026, to advance a ruggedized daisy petal biomanufacturing system from technology readiness level 4 to level 7, enabling production of protein-based medical countermeasures for warfighter use in remote and austere environments. The OTA sits outside the Federal Acquisition Regulation and operates under the statutory authorities governing prototype and production projects. Performance extends through May 31, 2029, with work conducted in Medford, Massachusetts. This effort bridges development and manufacturing maturity for a platform designed to support distributed, field-deployable bioproduction capabilities.
Generated 7/10/26, 9:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/9/26 |